Global Genetic Counseling Market: Focus on Counseling Approach, Key Players Type, Counseling Channel, Type of Service, Application, Target Population, Level of Service, Country Data and Competitive Landscape - Analysis and Forecast, 2019-2030
Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request.
Market Report Coverage - Genetic Counseling
Market Segmentation
InformedDNA, Integrated Genetics (Laboratory Corporation of America), Quest Diagnostics Incorporated, Genome Medical, ARUP Laboratories, Invitae Corporation, GeneMatters, and MyOncoPath.
Key Questions Answered in this Report:
Genetic Counseling is a communication process that intends to assist at-risk or affected individuals and families in understanding the disease risks, mode of transmission, and natural history of a genetic disorder. The approach also facilitates informed consent for genetic tests when required, in settings such as family planning and risk management services.
Traditionally, the genetic counseling support services had mainly been offered for settings such as indication risk assessment and other segments of prenatal/preconception, and pediatric risk care. However, with the advent of new players in the genetic counseling market, pharmacogenomic services and diagnostic counseling services have become an eminent part of current diagnostic and treatment practices. Several players, such as Genome Medical and MyOncoPath, are currently offering these services in the market. The entry of new players in the market, coupled up with increased innovation pertaining to cost mitigation and resource output maximization had transformed the market currently.
The existing market of genetic counseling is favored by multiple factors, which include rising government initiatives, coupled up with general population’s growing awareness pertaining to genetic conditions. Additionally, the increasing number of genetic counselors in both industry and hospital settings is also one of the key driving factors for genetic counseling market.
Within the research report, the market is segmented on the basis of key players business model (core genetic counseling company, clinical genetic testing company, and direct-to-consumer testing company), genetic counseling approach (integrated counseling, discretionary counseling, and independent counseling services), level of counseling (pre- and post-counseling support), target population (general population and patients), type of service (risk assessment counseling and pharmacogenomic counseling), application( prenatal/preconception care, pediatric care, indication risk assessment, and genetic counseling for intent-to-treat patients), counseling channel (providers and self-referred individuals) and region (North America, Europe, Asia Pacific and Rest-of-the-World). This segmentation highlights value propositions and business models useful for industry leaders and stakeholders. The research also comprises country-level analysis, go-to-market strategies of leading players, future opportunities, among others, to detail the scope and provide a 360-coverage of the domain.
Competitive Landscape
Major players, including Genome Medical, GeneMatters, Fulgent Genetics, and InformedDNA, among others, led the number of synergistic developments (partnerships and alliances) witnessed by the market. On the basis of region, North America is expected to retain a leading position throughout the forecast period 2020-2030, followed by Europe. This is a result of the presence of leading industry players in this region, coupled up with a rising number of genetic conditions.
Market Report Coverage - Genetic Counseling
Market Segmentation
- By Key Players Business Model: Core Genetic Counseling Companies, Direct-to-Consumer Genetic Testing Companies, and Clinical Genetic Testing Companies
- By Counseling Approach: Integrated, Independent, and Discretionary Genetic Counseling
- By Level of Service: Pre- and Post-Genetic Counseling Services
- By Target Population: General Population and Intent-to-Treat Patient Population
- By Type of Service: Risk Assessment Counseling and Pharmacogenomic Counseling
- By Type of Application: Prenatal/Preconception Care, Pediatric Care, Indication Risk Assessment, and Genetic Counseling for Intent-to-Treat Patients
- By Type of Counseling Channel: Providers and Self-Referred Individuals
- By Region: North America, Europe, Asia Pacific, and Rest-of-the-World
- North America – U.S., Canada
- Europe – Germany, U.K., France, Italy, Spain, Romania, Netherlands, Norway, Rest-of-Europe
- Asia-Pacific – China, Japan, India, Taiwan, New Zealand, South Korea, Australia, Rest-of-APAC
- Rest-of-the-World
- Rapid Rise in Number of Genetic Counselors’ Workforce
- Increasing Adoption of Inorganic Growth Strategies in the Market
- Rising Demand of Prenatal and Preconception Genetic Support Services in Major Geographies
- Limited Reimbursement Among Major Insurance Providers
- Lack of Genetic Counselors
- Healthcare Costs Mitigation
- Expected Implementation of H.R. 3235 Bill in the U.S.
- Entry of New Genetic Counseling Platforms to Maximize Counselors’ Productivity
InformedDNA, Integrated Genetics (Laboratory Corporation of America), Quest Diagnostics Incorporated, Genome Medical, ARUP Laboratories, Invitae Corporation, GeneMatters, and MyOncoPath.
Key Questions Answered in this Report:
- What is genetic counseling? How different settings for genetic counseling has evolved over the centuries?
- What are the major market drivers, challenges, and opportunities in the global genetic counseling market?
- What was the global genetic counseling market size in terms of revenue in 2019? How is the market expected to evolve in the upcoming years? What is the expected market size in 2030?
- How is each segment of the global genetic counseling market expected to grow during the forecast period between 2020 to 2030, and what revenue is expected to be generated by each of the segments by the end of 2030?
- What are the developmental strategies implemented by the key players to sustain in the competitive market?
- What is the growth potential of the global genetic counseling in several countries globally?
- Which service segment among the four (proactive indication risk assessment, prenatal/preconception, pediatric, or pharmacogenomic) are offered by key players such as Integrated Genetics (Laboratory Corporation of America), InformedDNA, Genome Medical, Quest Diagnostics Incorporated, MyOncoPath, among others?
- Which genetic counseling approach was leading the market in 2019 and is expected to dominate the market in 2030, and why?
- Which application type is leading the market in 2019 and is expected to dominate the market in 2030 and why?
- Which region dominated the global genetic counseling market in 2019, and what are the expected trends from each of the regions in the forecast period 2020-2030?
Genetic Counseling is a communication process that intends to assist at-risk or affected individuals and families in understanding the disease risks, mode of transmission, and natural history of a genetic disorder. The approach also facilitates informed consent for genetic tests when required, in settings such as family planning and risk management services.
Traditionally, the genetic counseling support services had mainly been offered for settings such as indication risk assessment and other segments of prenatal/preconception, and pediatric risk care. However, with the advent of new players in the genetic counseling market, pharmacogenomic services and diagnostic counseling services have become an eminent part of current diagnostic and treatment practices. Several players, such as Genome Medical and MyOncoPath, are currently offering these services in the market. The entry of new players in the market, coupled up with increased innovation pertaining to cost mitigation and resource output maximization had transformed the market currently.
The existing market of genetic counseling is favored by multiple factors, which include rising government initiatives, coupled up with general population’s growing awareness pertaining to genetic conditions. Additionally, the increasing number of genetic counselors in both industry and hospital settings is also one of the key driving factors for genetic counseling market.
Within the research report, the market is segmented on the basis of key players business model (core genetic counseling company, clinical genetic testing company, and direct-to-consumer testing company), genetic counseling approach (integrated counseling, discretionary counseling, and independent counseling services), level of counseling (pre- and post-counseling support), target population (general population and patients), type of service (risk assessment counseling and pharmacogenomic counseling), application( prenatal/preconception care, pediatric care, indication risk assessment, and genetic counseling for intent-to-treat patients), counseling channel (providers and self-referred individuals) and region (North America, Europe, Asia Pacific and Rest-of-the-World). This segmentation highlights value propositions and business models useful for industry leaders and stakeholders. The research also comprises country-level analysis, go-to-market strategies of leading players, future opportunities, among others, to detail the scope and provide a 360-coverage of the domain.
Competitive Landscape
Major players, including Genome Medical, GeneMatters, Fulgent Genetics, and InformedDNA, among others, led the number of synergistic developments (partnerships and alliances) witnessed by the market. On the basis of region, North America is expected to retain a leading position throughout the forecast period 2020-2030, followed by Europe. This is a result of the presence of leading industry players in this region, coupled up with a rising number of genetic conditions.
Executive Summary
1 PRODUCT DEFINITION
1.1 Inclusion and Exclusion
2 MARKET SCOPE
2.1 Scope of Work
2.2 Key Questions Answered in the Report
3 RESEARCH METHODOLOGY
3.1 Global Genetic Counseling Market: Research Methodology
3.2 Data Sources
3.3 Secondary Data Sources
3.4 Market Estimation Model
3.5 Criteria for Company Profiling
4 MARKET OVERVIEW
4.1 Industry Participants, Landscape, and Recent Trends
4.2 Genetic Counselors Statistics
5 INDUSTRY INSIGHTS
5.1 Active Organizations for Genetic Counseling Regulation
5.2 Guidelines and Regulation for Genetic Counseling
5.2.1 U.S.
5.2.1.1 Guidelines
5.2.1.2 Regulation
5.2.2 Europe
5.2.2.1 Guidelines
5.2.2.2 Regulation
5.2.3 Australia
5.2.3.1 Guidelines
5.2.3.2 Regulation
5.3 Reimbursement Scenario
5.3.1 U.S.
5.3.2 Europe
5.3.3 Australia
6 MARKET DYNAMICS
6.1 Market Drivers
6.1.1 Rapid Rise in Number of Genetic Counselors Workforce
6.1.2 Increasing Adoption of Inorganic Growth Strategies in the Market
6.1.3 Rising Demand of Prenatal and Preconception Genetic Support Services in Major Geographies
6.2 Restraints
6.2.1 Limited Reimbursement Among Major Insurance Providers
6.2.2 Lack of Genetic Counselors
6.3 Market Opportunities
6.3.1 Healthcare Costs Mitigation
6.3.2 Expected Implementation of H.R. 3235 Bill in the U.S.
6.3.3 Entry of New Genetic Counseling Platforms to Maximize Counselors’ Productivity
7 COMPETITIVE LANDSCAPE
7.1 Key Strategies and Developments
7.1.1 Synergistic Activities
7.1.2 Regulatory Accreditations
7.1.3 Service Launches
7.1.4 Acquisitions, Mergers and Spin-offs
7.2 Service Scenario
7.2.1 Funding Scenario
7.3 Market Share Analysis
7.4 Growth-Share Analysis (Opportunity Mapping)
7.4.1 By Company
7.4.2 By Target Population
7.4.3 By Counseling Approach
7.4.4 By Application
8 GLOBAL GENETIC COUNSELING MARKET (BY COUNSELING APPROACH)
8.1 Integrated Genetic Counseling
8.2 Discretionary Genetic Counseling
8.3 Independent Genetic Counseling
9 GLOBAL GENETIC COUNSELING MARKET (BY KEY PLAYERS BUSINESS MODEL)
9.1 Core Genetic Counseling Companies
9.2 Direct-to-Consumer Testing Companies
9.3 Clinical Genetic Testing Companies
10 GLOBAL GENETIC COUNSELING MARKET (BY CHANNEL)
10.1 Providers
10.2 Self-Referred Individuals
11 GLOBAL GENETIC COUNSELING MARKET (BY TYPE OF SERVICE)
11.1 Risk Assessment
11.2 Pharmacogenomics
11.3 Other Genetic Counseling Services
12 GLOBAL GENETIC COUNSELING MARKET (BY APPLICATION)
12.1 Proactive Risk Assessment
12.2 GC For Intent-to-Treat Patients (ITT)
12.3 Prenatal and Preconception Care
12.4 Pediatric Care
12.5 Other Genetic Counseling Applications
13 GLOBAL GENETIC COUNSELING MARKET (BY TARGET POPULATION SEGMENT)
13.1 General Population
13.2 Patient Population
14 GLOBAL GENETIC COUNSELING MARKET (BY LEVEL OF SERVICE)
14.1 Pre-counseling Support
14.2 Post Counseling Support
15 GLOBAL GENETIC COUNSELING MARKET (BY REGION)
15.1 Overview
15.2 North America
15.2.1 U.S.
15.2.2 Canada
15.3 Europe
15.3.1 Germany
15.3.2 U.K.
15.3.3 France
15.3.4 Italy
15.3.5 Spain
15.3.6 Romania
15.3.7 Netherlands
15.3.8 Norway
15.3.9 Rest-of-Europe
15.4 Asia-Pacific
15.4.1 China
15.4.2 Japan
15.4.3 India
15.4.4 Taiwan
15.4.5 New Zealand
15.4.6 South Korea
15.4.7 Australia
15.4.8 Rest-of-APAC
15.5 Rest-of-the-World
16 COMPANY PROFILES
16.1 Overview
16.2 Quest Diagnostics Incorporated
16.2.1 Company Overview
16.2.2 Role of Quest Diagnostics Incorporated in the Global Genetic Counseling Market
16.2.3 Financials
16.2.4 SWOT Analysis
16.3 Invitae Corporation
16.3.1 Company Overview
16.3.2 Role of Invitae Corporation, Inc. in the Global Genetic Counseling Market
16.3.3 Financials
16.3.4 SWOT Analysis
16.4 Laboratory Corporation of America
16.4.1 Company Overview
16.4.2 Role of Laboratory Corporation of America Holdings in the Global Genetic Counseling Market
16.4.3 Financials
16.4.4 SWOT Analysis
16.5 Arup Laboratories
16.5.1 Company Overview
16.5.2 Role of ARUP Laboratories in the Global Genetic Counseling Market
16.5.3 SWOT Analysis
16.6 Genome Medical
16.6.1 Company Overview
16.6.2 Role of Genome Medical in the Global Genetic Counseling Market
16.6.3 SWOT Analysis
16.7 MyOncoPath
16.7.1 Company Overview
16.7.2 Role of MyOncoPath in the Genetic Counseling Market
16.7.3 SWOT Analysis
16.8 GeneMatters
16.8.1 Company Overview
16.8.2 Role of GeneMatters in the Genetic Counseling Market
16.8.3 SWOT Analysis
16.9 EasyDNA
16.9.1 Company Overview
16.9.2 Role of EasyDNA in the Global Genetic Counseling Market
16.9.3 SWOT Analysis
16.1 AT-GC
16.10.1 Company Overview
16.10.2 Role of AT-GC in the Global Genetic Counseling Market
16.10.3 SWOT Analysis
16.11 Biron Health Group
16.11.1 Company Overview
16.11.2 Role of Biron Health Group in the Global Genetic Counseling Market
16.11.3 SWOT Analysis
16.12 Metis Genetics
16.12.1 Company Overview
16.12.2 Role of Metis Genetics in the Global Genetic Counseling Market
16.12.3 SWOT Analysis
16.13 GeneScreen
16.13.1 Company Overview
16.13.2 Role of GeneScreen in the Global Genetic Counseling Market
16.13.3 SWOT Analysis
16.14 GeneHealth UK
16.14.1 Company Overview
16.14.2 Role of GeneHealth UK in the Global Genetic Counseling Market
16.14.3 SWOT Analysis
16.15 Veritas Genetics
16.15.1 Company Overview
16.15.2 Role of Veritas Genetics in the Global Genetic Counseling Market
16.15.3 SWOT Analysis
16.16 InformedDNA
16.16.1 Company Overview
16.16.2 Role of InformedDNA in the Global Genetic Counseling Market
16.16.3 SWOT Analysis
16.17 Ancestry
16.17.1 Company Overview
16.17.2 Role of Ancestry in the Global Genetic Counseling Market
16.17.3 SWOT Analysis
16.18 Color Genomics
16.18.1 Company Overview
16.18.2 Role of Color Genomics in the Global Genetic Counseling Market
16.18.3 SWOT Analysis
16.19 GeneDX (an Opko Health Company)
16.19.1 Company Overview
16.19.2 Role of GeneDX in the Global Genetic Counseling Market
16.19.3 SWOT Analysis
16.2 GenPath Diagnostics (an Opko Health Company)
16.20.1 Company Overview
16.20.2 Role of GenPath Diagnostics in the Global Genetic Counseling Market
16.20.3 SWOT Analysis
1 PRODUCT DEFINITION
1.1 Inclusion and Exclusion
2 MARKET SCOPE
2.1 Scope of Work
2.2 Key Questions Answered in the Report
3 RESEARCH METHODOLOGY
3.1 Global Genetic Counseling Market: Research Methodology
3.2 Data Sources
3.3 Secondary Data Sources
3.4 Market Estimation Model
3.5 Criteria for Company Profiling
4 MARKET OVERVIEW
4.1 Industry Participants, Landscape, and Recent Trends
4.2 Genetic Counselors Statistics
5 INDUSTRY INSIGHTS
5.1 Active Organizations for Genetic Counseling Regulation
5.2 Guidelines and Regulation for Genetic Counseling
5.2.1 U.S.
5.2.1.1 Guidelines
5.2.1.2 Regulation
5.2.2 Europe
5.2.2.1 Guidelines
5.2.2.2 Regulation
5.2.3 Australia
5.2.3.1 Guidelines
5.2.3.2 Regulation
5.3 Reimbursement Scenario
5.3.1 U.S.
5.3.2 Europe
5.3.3 Australia
6 MARKET DYNAMICS
6.1 Market Drivers
6.1.1 Rapid Rise in Number of Genetic Counselors Workforce
6.1.2 Increasing Adoption of Inorganic Growth Strategies in the Market
6.1.3 Rising Demand of Prenatal and Preconception Genetic Support Services in Major Geographies
6.2 Restraints
6.2.1 Limited Reimbursement Among Major Insurance Providers
6.2.2 Lack of Genetic Counselors
6.3 Market Opportunities
6.3.1 Healthcare Costs Mitigation
6.3.2 Expected Implementation of H.R. 3235 Bill in the U.S.
6.3.3 Entry of New Genetic Counseling Platforms to Maximize Counselors’ Productivity
7 COMPETITIVE LANDSCAPE
7.1 Key Strategies and Developments
7.1.1 Synergistic Activities
7.1.2 Regulatory Accreditations
7.1.3 Service Launches
7.1.4 Acquisitions, Mergers and Spin-offs
7.2 Service Scenario
7.2.1 Funding Scenario
7.3 Market Share Analysis
7.4 Growth-Share Analysis (Opportunity Mapping)
7.4.1 By Company
7.4.2 By Target Population
7.4.3 By Counseling Approach
7.4.4 By Application
8 GLOBAL GENETIC COUNSELING MARKET (BY COUNSELING APPROACH)
8.1 Integrated Genetic Counseling
8.2 Discretionary Genetic Counseling
8.3 Independent Genetic Counseling
9 GLOBAL GENETIC COUNSELING MARKET (BY KEY PLAYERS BUSINESS MODEL)
9.1 Core Genetic Counseling Companies
9.2 Direct-to-Consumer Testing Companies
9.3 Clinical Genetic Testing Companies
10 GLOBAL GENETIC COUNSELING MARKET (BY CHANNEL)
10.1 Providers
10.2 Self-Referred Individuals
11 GLOBAL GENETIC COUNSELING MARKET (BY TYPE OF SERVICE)
11.1 Risk Assessment
11.2 Pharmacogenomics
11.3 Other Genetic Counseling Services
12 GLOBAL GENETIC COUNSELING MARKET (BY APPLICATION)
12.1 Proactive Risk Assessment
12.2 GC For Intent-to-Treat Patients (ITT)
12.3 Prenatal and Preconception Care
12.4 Pediatric Care
12.5 Other Genetic Counseling Applications
13 GLOBAL GENETIC COUNSELING MARKET (BY TARGET POPULATION SEGMENT)
13.1 General Population
13.2 Patient Population
14 GLOBAL GENETIC COUNSELING MARKET (BY LEVEL OF SERVICE)
14.1 Pre-counseling Support
14.2 Post Counseling Support
15 GLOBAL GENETIC COUNSELING MARKET (BY REGION)
15.1 Overview
15.2 North America
15.2.1 U.S.
15.2.2 Canada
15.3 Europe
15.3.1 Germany
15.3.2 U.K.
15.3.3 France
15.3.4 Italy
15.3.5 Spain
15.3.6 Romania
15.3.7 Netherlands
15.3.8 Norway
15.3.9 Rest-of-Europe
15.4 Asia-Pacific
15.4.1 China
15.4.2 Japan
15.4.3 India
15.4.4 Taiwan
15.4.5 New Zealand
15.4.6 South Korea
15.4.7 Australia
15.4.8 Rest-of-APAC
15.5 Rest-of-the-World
16 COMPANY PROFILES
16.1 Overview
16.2 Quest Diagnostics Incorporated
16.2.1 Company Overview
16.2.2 Role of Quest Diagnostics Incorporated in the Global Genetic Counseling Market
16.2.3 Financials
16.2.4 SWOT Analysis
16.3 Invitae Corporation
16.3.1 Company Overview
16.3.2 Role of Invitae Corporation, Inc. in the Global Genetic Counseling Market
16.3.3 Financials
16.3.4 SWOT Analysis
16.4 Laboratory Corporation of America
16.4.1 Company Overview
16.4.2 Role of Laboratory Corporation of America Holdings in the Global Genetic Counseling Market
16.4.3 Financials
16.4.4 SWOT Analysis
16.5 Arup Laboratories
16.5.1 Company Overview
16.5.2 Role of ARUP Laboratories in the Global Genetic Counseling Market
16.5.3 SWOT Analysis
16.6 Genome Medical
16.6.1 Company Overview
16.6.2 Role of Genome Medical in the Global Genetic Counseling Market
16.6.3 SWOT Analysis
16.7 MyOncoPath
16.7.1 Company Overview
16.7.2 Role of MyOncoPath in the Genetic Counseling Market
16.7.3 SWOT Analysis
16.8 GeneMatters
16.8.1 Company Overview
16.8.2 Role of GeneMatters in the Genetic Counseling Market
16.8.3 SWOT Analysis
16.9 EasyDNA
16.9.1 Company Overview
16.9.2 Role of EasyDNA in the Global Genetic Counseling Market
16.9.3 SWOT Analysis
16.1 AT-GC
16.10.1 Company Overview
16.10.2 Role of AT-GC in the Global Genetic Counseling Market
16.10.3 SWOT Analysis
16.11 Biron Health Group
16.11.1 Company Overview
16.11.2 Role of Biron Health Group in the Global Genetic Counseling Market
16.11.3 SWOT Analysis
16.12 Metis Genetics
16.12.1 Company Overview
16.12.2 Role of Metis Genetics in the Global Genetic Counseling Market
16.12.3 SWOT Analysis
16.13 GeneScreen
16.13.1 Company Overview
16.13.2 Role of GeneScreen in the Global Genetic Counseling Market
16.13.3 SWOT Analysis
16.14 GeneHealth UK
16.14.1 Company Overview
16.14.2 Role of GeneHealth UK in the Global Genetic Counseling Market
16.14.3 SWOT Analysis
16.15 Veritas Genetics
16.15.1 Company Overview
16.15.2 Role of Veritas Genetics in the Global Genetic Counseling Market
16.15.3 SWOT Analysis
16.16 InformedDNA
16.16.1 Company Overview
16.16.2 Role of InformedDNA in the Global Genetic Counseling Market
16.16.3 SWOT Analysis
16.17 Ancestry
16.17.1 Company Overview
16.17.2 Role of Ancestry in the Global Genetic Counseling Market
16.17.3 SWOT Analysis
16.18 Color Genomics
16.18.1 Company Overview
16.18.2 Role of Color Genomics in the Global Genetic Counseling Market
16.18.3 SWOT Analysis
16.19 GeneDX (an Opko Health Company)
16.19.1 Company Overview
16.19.2 Role of GeneDX in the Global Genetic Counseling Market
16.19.3 SWOT Analysis
16.2 GenPath Diagnostics (an Opko Health Company)
16.20.1 Company Overview
16.20.2 Role of GenPath Diagnostics in the Global Genetic Counseling Market
16.20.3 SWOT Analysis
LIST OF TABLES
Table 4.1: Global Genetic Counseling Market, by Region, ($Million), 2019-2030
Table 4.2: Genetic Counselors Statistics (by Country)
Table 5.1: Active Organization for Genetic Counseling
Table 5.2: Companies and Relative Coverage Status in the U.S.
Table 5.3: Companies and Relative Coverage Status in the Europe
Table 5.4: Companies and Relative Coverage Status in the Australia
Table 4.1: Global Genetic Counseling Market, by Region, ($Million), 2019-2030
Table 4.2: Genetic Counselors Statistics (by Country)
Table 5.1: Active Organization for Genetic Counseling
Table 5.2: Companies and Relative Coverage Status in the U.S.
Table 5.3: Companies and Relative Coverage Status in the Europe
Table 5.4: Companies and Relative Coverage Status in the Australia
LIST OF FIGURES
Figure 1: Impact Analysis of Market Drivers and Market Challenges on the Global Genetic Counseling Market
Figure 2: Global Genetic Counseling Market (by Key Players’ Business Model), $Million, 2019 and 2030
Figure 3: Global Genetic Counseling Market (by Counseling Approach), $Million, 2019 and 2030
Figure 4: Global Genetic Counseling Market (by Counseling Channel), $Million, 2019 and 2030
Figure 5: Global Genetic Counseling Market (by Type of Service), $Million, 2019 and 2030
Figure 6: Global Genetic Counseling Market (by Application), $Million, 2019 and 2030
Figure 7: Global Genetic Counseling Market (by Target Population), $Million, 2019 and 2030
Figure 8: Global Genetic Counseling Market (by Level of Service), $Million, 2019 and 2030
Figure 9: Global Genetic Counseling Market (by Region), $Million, 2019
Figure 2.1: Global Genetic Counseling Market Segmentation
Figure 3.1: Global Genetic Counseling Market Research Methodology
Figure 3.2: Primary Research Methodology
Figure 3.3: Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.4: Top-Down Approach (Segment-Wise Analysis)
Figure 4.1: Global Genetic Counseling Market, 2019-2030 ($Million)
Figure 4.2: Genetic Counseling Companies as Per Business Model
Figure 4.3: Approaches for Genetic Counseling
Figure 4.4: Key Strategies Adopted by Market Players
Figure 4.5: Genetic Counselors Statistics and Active Hospital Networks in North America
Figure 4.6: Genetic Counselors Statistics and Active Hospital Networks in Europe, APAC, and Rest-of-the-World (RoW)
Figure 5.1: Genetic Counseling Guidelines Adopted in the U.S.
Figure 5.2: Licensure Status for Genetic Counselors in the U.S.
Figure 5.3: HGSA Genetic Counseling Guidelines
Figure 5.4: Genetic Counseling Regulatory Authorities in Australia
Figure 6.1: Market Dynamics of Global Genetic Counseling Market
Figure 6.2: Number of Genetic Counselors in the U.S., 2010-2018
Figure 6.3: Synergistic Activities, 2017-2019
Figure 7.1: Share of Key Developments and Strategies, January 2017-December 2019
Figure 7.2: Synergistic Activities Share (by Company), January 2017-December 2019
Figure 7.3: Accreditations Share (by Company), January 2017-December 2019
Figure 7.4: Service Launches Share (by Company), January 2017-December 2019
Figure 7.5: Acquisitions, Mergers and Spin-offs Share (by Company), January 2017-December 2019
Figure 7.6: Genetic Counseling Funding Scenario
Figure 7.7: Market Share Analysis for Global Genetic Counseling Market, 2019
Figure 7.8: Growth-Share Matrix for Global Genetic Counseling Market (by Company), 2019
Figure 7.9: Growth-Share Matrix for Global Genetic Counseling Market (by Target Population), 2019-2030
Figure 7.10: Growth-Share Matrix for Global Genetic Counseling Market (by Counseling Approach), 2019-2030
Figure 7.11: Growth-Share Matrix for Global Genetic Counseling Market (by Application), 2019-2030
Figure 8.1: Global Genetic Counseling Market (by Counseling Approach), 2019 vs. 2030
Figure 8.2: Integrated Genetic Counseling Market, $Million, 2019-2030
Figure 8.3: Discretionary Genetic Counseling Market, $Million, 2019-2030
Figure 8.4: Independent Genetic Counseling Market, $Million, 2019-2030
Figure 9.1: Global Genetic Counseling Market (by Key Players’ Business Model), 2019 vs 2030
Figure 9.2: Genetic Counseling Market by Core Genetic Counseling Segment, $Million, 2019-2030
Figure 9.3: Genetic Counseling Market by Direct-to-Consumer Testing Segment, $Million, 2019-2030
Figure 9.4: Genetic Counseling Market (by Clinical Genetic Testing Segment), $Million, 2019-2030
Figure 10.1: Global Genetic Counseling Market (by Counseling Channel), 2019 vs. 2030
Figure 10.2: Genetic Counseling Market by Provider Segment, $Million, 2019-2030
Figure 10.3: Genetic Counseling Market by Self-Referred Individuals Segment, $Million, 2019-2030
Figure 11.1: Global Genetic Counseling Market (by Type of Service), 2019 vs. 2030
Figure 11.2: Genetic Counseling Market by Risk Assessment Segment, $Million, 2019-2030
Figure 11.3: Genetic Counseling Market by Pharmacogenomics Segment, $Million, 2019-2030
Figure 11.4: Genetic Counseling Market by Other Genetic Counseling Services Segment, $Million, 2019-2030
Figure 12.1: Global Genetic Counseling Market (by Application), 2019 vs. 2030
Figure 12.2: Indication Risk Assessment Market, $Million, 2019-2030
Figure 12.3: Intent-to-treat patients Intent-to-treat Patients Market, $Million, 2019-2030
Figure 12.4: Prenatal/Preconception Care Market, $Million, 2019-2030
Figure 12.5: Pediatric Care Market, $Million, 2019-2030
Figure 12.6: Other GC Applications Market, $Million, 2019-2030
Figure 13.1: Global Genetic Counseling Market (by Target Population), 2019 vs. 2030
Figure 13.2: Global Genetic Counseling Market by General Population Segment, $Million, 2019-2030
Figure 13.3: Global Genetic Counseling Market by Patient Population Segment, $Million, 2019-2030
Figure 14.1: Global Genetic Counseling Market (by Level of Service), 2019 vs 2030
Figure 14.2: Global Genetic Counseling Market by Pre-counseling Support, $Million, 2019-2030
Figure 14.3: Global Genetic Counseling Market by Post-counseling Support, $Million, 2019-2030
Figure 15.1: Global Genetic Counseling Market (by Region), $Million, 2019 vs. 2030
Figure 15.2: North America: Market Dynamics
Figure 15.3: North America Genetic Counseling Market, $Million, 2019-2030
Figure 15.4: North America Genetic Counseling Market (by Country), $Million, 2019 vs 2030
Figure 15.5: U.S. Genetic Counseling Market, $Million, 2019-2030
Figure 15.6: Key Drivers of the U.S. Genetic Counseling Market
Figure 15.7: Canada Genetic Counseling Market, $Million, 2019-2030
Figure 15.8: Europe: Market Dynamics
Figure 15.9: Europe Genetic Counseling Market, $Million, 2019-2030
Figure 15.10: Europe Genetic Counseling Market (by Country), $Million, 2019 vs. 2030
Figure 15.11: Germany Genetic Counseling Market, $Million, 2019-2030
Figure 15.12: U.K. Genetic Counseling Market, $Million, 2019-2030
Figure 15.13: France Genetic Counseling Market, $Million, 2019-2030
Figure 15.14: Italy Genetic Counseling Market, $Million, 2019-2030
Figure 15.15: Spain Genetic Counseling Market, $Million, 2019-2030
Figure 15.16: Romania Genetic Counseling Market, $Million, 2019-2030
Figure 15.17: Netherlands Genetic Counseling Market, $Million, 2019-2030
Figure 15.18: Norway Genetic Counseling Market, $Million, 2019-2030
Figure 15.19: Rest-of-Europe Genetic Counseling Market, $Million, 2019-2030
Figure 15.20: Asia-Pacific: Market Dynamics
Figure 15.21: Asia-Pacific Genetic Counseling Market, $Million, 2019-2030
Figure 15.22: Asia-Pacific Genetic Counseling Market (by Country), $Million, 2019 vs. 2030
Figure 15.23: China Genetic Counseling Market, $Million, 2019-2030
Figure 15.24: Japan Genetic Counseling Market, $Million, 2019-2030
Figure 15.25: India Genetic Counseling Market, $Million, 2019-2030
Figure 15.26: Taiwan Genetic Counseling Market, $Million, 2019-2030
Figure 15.27: New Zealand Genetic Counseling Market, $Million, 2019-2030
Figure 15.28: South Korea Genetic Counseling Market, $Million, 2019-2030
Figure 15.29: Australia Genetic Counseling Market, $Million, 2019-2030
Figure 15.30: Rest-of-APAC Genetic Counseling Market, $Million, 2019-2030
Figure 15.31: Rest-of-the-World: Market Dynamics
Figure 15.32: Rest-of-the-World Genetic Counseling Market, $Million, 2019-2030
Figure 16.1: Total Number of Companies Profiled
Figure 16.2: Quest Diagnostics Incorporated: Portfolio
Figure 16.3: Quest Diagnostics Incorporated: Overall Financials, 2017-2019
Figure 16.4: Quest Diagnostics Incorporated: Revenue (by Business Segment), 2017-2019
Figure 16.5: Quest Diagnostics Incorporated: SWOT Analysis
Figure 16.6: Invitae Corporation: Portfolio
Figure 16.7: Invitae Corporation: Overall Financials, 2017-2019
Figure 16.8: Invitae Corporation: Revenue (by Segment), 2017-2019
Figure 16.9: Invitae Corporation: Revenue (by Geography), 2017-2019
Figure 16.10: Invitae Corporation: R&D Expenditure, 2017-2019
Figure 16.11: Invitae Corporation: SWOT Analysis
Figure 16.12: Laboratory Corporation of America Holdings: Service Portfolio
Figure 16.13: Laboratory Corporation of America Holdings: Overall Financials, 2017-2019
Figure 16.14: Laboratory Corporation of America Holdings: Revenue (by Segment), 2017-2019
Figure 16.15: Laboratory Corporation of America Holdings: Revenue (by Region), 2019
Figure 16.16: Laboratory Corporation of America Holdings: SWOT Analysis
Figure 16.17: ARUP Laboratories: SWOT Analysis
Figure 16.18: Genome Medical: SWOT Analysis
Figure 16.19: MyOncoPath: SWOT Analysis
Figure 16.20: GeneMatters: SWOT Analysis
Figure 16.21: EasyDNA: SWOT Analysis
Figure 16.22: AT-GC: SWOT Analysis
Figure 16.23: Biron Health Group: SWOT Analysis
Figure 16.24: Metis Genetics: SWOT Analysis
Figure 16.25: Gene Screen: SWOT Analysis
Figure 16.26: GeneHealth UK: SWOT Analysis
Figure 16.27: Veritas Genetics: SWOT Analysis
Figure 16.28: Informed DNA: SWOT Analysis
Figure 16.29: Ancestry: SWOT Analysis
Figure 16.30: Color Genomics: SWOT Analysis
Figure 16.31: GeneDX: SWOT Analysis
Figure 16.32: GenPath Diagnostics: SWOT Analysis
Figure 1: Impact Analysis of Market Drivers and Market Challenges on the Global Genetic Counseling Market
Figure 2: Global Genetic Counseling Market (by Key Players’ Business Model), $Million, 2019 and 2030
Figure 3: Global Genetic Counseling Market (by Counseling Approach), $Million, 2019 and 2030
Figure 4: Global Genetic Counseling Market (by Counseling Channel), $Million, 2019 and 2030
Figure 5: Global Genetic Counseling Market (by Type of Service), $Million, 2019 and 2030
Figure 6: Global Genetic Counseling Market (by Application), $Million, 2019 and 2030
Figure 7: Global Genetic Counseling Market (by Target Population), $Million, 2019 and 2030
Figure 8: Global Genetic Counseling Market (by Level of Service), $Million, 2019 and 2030
Figure 9: Global Genetic Counseling Market (by Region), $Million, 2019
Figure 2.1: Global Genetic Counseling Market Segmentation
Figure 3.1: Global Genetic Counseling Market Research Methodology
Figure 3.2: Primary Research Methodology
Figure 3.3: Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.4: Top-Down Approach (Segment-Wise Analysis)
Figure 4.1: Global Genetic Counseling Market, 2019-2030 ($Million)
Figure 4.2: Genetic Counseling Companies as Per Business Model
Figure 4.3: Approaches for Genetic Counseling
Figure 4.4: Key Strategies Adopted by Market Players
Figure 4.5: Genetic Counselors Statistics and Active Hospital Networks in North America
Figure 4.6: Genetic Counselors Statistics and Active Hospital Networks in Europe, APAC, and Rest-of-the-World (RoW)
Figure 5.1: Genetic Counseling Guidelines Adopted in the U.S.
Figure 5.2: Licensure Status for Genetic Counselors in the U.S.
Figure 5.3: HGSA Genetic Counseling Guidelines
Figure 5.4: Genetic Counseling Regulatory Authorities in Australia
Figure 6.1: Market Dynamics of Global Genetic Counseling Market
Figure 6.2: Number of Genetic Counselors in the U.S., 2010-2018
Figure 6.3: Synergistic Activities, 2017-2019
Figure 7.1: Share of Key Developments and Strategies, January 2017-December 2019
Figure 7.2: Synergistic Activities Share (by Company), January 2017-December 2019
Figure 7.3: Accreditations Share (by Company), January 2017-December 2019
Figure 7.4: Service Launches Share (by Company), January 2017-December 2019
Figure 7.5: Acquisitions, Mergers and Spin-offs Share (by Company), January 2017-December 2019
Figure 7.6: Genetic Counseling Funding Scenario
Figure 7.7: Market Share Analysis for Global Genetic Counseling Market, 2019
Figure 7.8: Growth-Share Matrix for Global Genetic Counseling Market (by Company), 2019
Figure 7.9: Growth-Share Matrix for Global Genetic Counseling Market (by Target Population), 2019-2030
Figure 7.10: Growth-Share Matrix for Global Genetic Counseling Market (by Counseling Approach), 2019-2030
Figure 7.11: Growth-Share Matrix for Global Genetic Counseling Market (by Application), 2019-2030
Figure 8.1: Global Genetic Counseling Market (by Counseling Approach), 2019 vs. 2030
Figure 8.2: Integrated Genetic Counseling Market, $Million, 2019-2030
Figure 8.3: Discretionary Genetic Counseling Market, $Million, 2019-2030
Figure 8.4: Independent Genetic Counseling Market, $Million, 2019-2030
Figure 9.1: Global Genetic Counseling Market (by Key Players’ Business Model), 2019 vs 2030
Figure 9.2: Genetic Counseling Market by Core Genetic Counseling Segment, $Million, 2019-2030
Figure 9.3: Genetic Counseling Market by Direct-to-Consumer Testing Segment, $Million, 2019-2030
Figure 9.4: Genetic Counseling Market (by Clinical Genetic Testing Segment), $Million, 2019-2030
Figure 10.1: Global Genetic Counseling Market (by Counseling Channel), 2019 vs. 2030
Figure 10.2: Genetic Counseling Market by Provider Segment, $Million, 2019-2030
Figure 10.3: Genetic Counseling Market by Self-Referred Individuals Segment, $Million, 2019-2030
Figure 11.1: Global Genetic Counseling Market (by Type of Service), 2019 vs. 2030
Figure 11.2: Genetic Counseling Market by Risk Assessment Segment, $Million, 2019-2030
Figure 11.3: Genetic Counseling Market by Pharmacogenomics Segment, $Million, 2019-2030
Figure 11.4: Genetic Counseling Market by Other Genetic Counseling Services Segment, $Million, 2019-2030
Figure 12.1: Global Genetic Counseling Market (by Application), 2019 vs. 2030
Figure 12.2: Indication Risk Assessment Market, $Million, 2019-2030
Figure 12.3: Intent-to-treat patients Intent-to-treat Patients Market, $Million, 2019-2030
Figure 12.4: Prenatal/Preconception Care Market, $Million, 2019-2030
Figure 12.5: Pediatric Care Market, $Million, 2019-2030
Figure 12.6: Other GC Applications Market, $Million, 2019-2030
Figure 13.1: Global Genetic Counseling Market (by Target Population), 2019 vs. 2030
Figure 13.2: Global Genetic Counseling Market by General Population Segment, $Million, 2019-2030
Figure 13.3: Global Genetic Counseling Market by Patient Population Segment, $Million, 2019-2030
Figure 14.1: Global Genetic Counseling Market (by Level of Service), 2019 vs 2030
Figure 14.2: Global Genetic Counseling Market by Pre-counseling Support, $Million, 2019-2030
Figure 14.3: Global Genetic Counseling Market by Post-counseling Support, $Million, 2019-2030
Figure 15.1: Global Genetic Counseling Market (by Region), $Million, 2019 vs. 2030
Figure 15.2: North America: Market Dynamics
Figure 15.3: North America Genetic Counseling Market, $Million, 2019-2030
Figure 15.4: North America Genetic Counseling Market (by Country), $Million, 2019 vs 2030
Figure 15.5: U.S. Genetic Counseling Market, $Million, 2019-2030
Figure 15.6: Key Drivers of the U.S. Genetic Counseling Market
Figure 15.7: Canada Genetic Counseling Market, $Million, 2019-2030
Figure 15.8: Europe: Market Dynamics
Figure 15.9: Europe Genetic Counseling Market, $Million, 2019-2030
Figure 15.10: Europe Genetic Counseling Market (by Country), $Million, 2019 vs. 2030
Figure 15.11: Germany Genetic Counseling Market, $Million, 2019-2030
Figure 15.12: U.K. Genetic Counseling Market, $Million, 2019-2030
Figure 15.13: France Genetic Counseling Market, $Million, 2019-2030
Figure 15.14: Italy Genetic Counseling Market, $Million, 2019-2030
Figure 15.15: Spain Genetic Counseling Market, $Million, 2019-2030
Figure 15.16: Romania Genetic Counseling Market, $Million, 2019-2030
Figure 15.17: Netherlands Genetic Counseling Market, $Million, 2019-2030
Figure 15.18: Norway Genetic Counseling Market, $Million, 2019-2030
Figure 15.19: Rest-of-Europe Genetic Counseling Market, $Million, 2019-2030
Figure 15.20: Asia-Pacific: Market Dynamics
Figure 15.21: Asia-Pacific Genetic Counseling Market, $Million, 2019-2030
Figure 15.22: Asia-Pacific Genetic Counseling Market (by Country), $Million, 2019 vs. 2030
Figure 15.23: China Genetic Counseling Market, $Million, 2019-2030
Figure 15.24: Japan Genetic Counseling Market, $Million, 2019-2030
Figure 15.25: India Genetic Counseling Market, $Million, 2019-2030
Figure 15.26: Taiwan Genetic Counseling Market, $Million, 2019-2030
Figure 15.27: New Zealand Genetic Counseling Market, $Million, 2019-2030
Figure 15.28: South Korea Genetic Counseling Market, $Million, 2019-2030
Figure 15.29: Australia Genetic Counseling Market, $Million, 2019-2030
Figure 15.30: Rest-of-APAC Genetic Counseling Market, $Million, 2019-2030
Figure 15.31: Rest-of-the-World: Market Dynamics
Figure 15.32: Rest-of-the-World Genetic Counseling Market, $Million, 2019-2030
Figure 16.1: Total Number of Companies Profiled
Figure 16.2: Quest Diagnostics Incorporated: Portfolio
Figure 16.3: Quest Diagnostics Incorporated: Overall Financials, 2017-2019
Figure 16.4: Quest Diagnostics Incorporated: Revenue (by Business Segment), 2017-2019
Figure 16.5: Quest Diagnostics Incorporated: SWOT Analysis
Figure 16.6: Invitae Corporation: Portfolio
Figure 16.7: Invitae Corporation: Overall Financials, 2017-2019
Figure 16.8: Invitae Corporation: Revenue (by Segment), 2017-2019
Figure 16.9: Invitae Corporation: Revenue (by Geography), 2017-2019
Figure 16.10: Invitae Corporation: R&D Expenditure, 2017-2019
Figure 16.11: Invitae Corporation: SWOT Analysis
Figure 16.12: Laboratory Corporation of America Holdings: Service Portfolio
Figure 16.13: Laboratory Corporation of America Holdings: Overall Financials, 2017-2019
Figure 16.14: Laboratory Corporation of America Holdings: Revenue (by Segment), 2017-2019
Figure 16.15: Laboratory Corporation of America Holdings: Revenue (by Region), 2019
Figure 16.16: Laboratory Corporation of America Holdings: SWOT Analysis
Figure 16.17: ARUP Laboratories: SWOT Analysis
Figure 16.18: Genome Medical: SWOT Analysis
Figure 16.19: MyOncoPath: SWOT Analysis
Figure 16.20: GeneMatters: SWOT Analysis
Figure 16.21: EasyDNA: SWOT Analysis
Figure 16.22: AT-GC: SWOT Analysis
Figure 16.23: Biron Health Group: SWOT Analysis
Figure 16.24: Metis Genetics: SWOT Analysis
Figure 16.25: Gene Screen: SWOT Analysis
Figure 16.26: GeneHealth UK: SWOT Analysis
Figure 16.27: Veritas Genetics: SWOT Analysis
Figure 16.28: Informed DNA: SWOT Analysis
Figure 16.29: Ancestry: SWOT Analysis
Figure 16.30: Color Genomics: SWOT Analysis
Figure 16.31: GeneDX: SWOT Analysis
Figure 16.32: GenPath Diagnostics: SWOT Analysis
